Literature DB >> 10650894

Current status of cancer patients' perception of alternative medicine in Japan. A preliminary cross-sectional survey.

K Eguchi1, I Hyodo, H Saeki.   

Abstract

Since there are no large-scale surveys of how cancer patients perceive unproven therapy in Japan, we wanted to clarify this issue by means of a cross-sectional questionnaire conducted among cancer patients. The survey revealed that 32% of cancer patients used unproven therapy without having sufficient information about it. There was a lack of communication between cancer patients and their physicians on topics relating to alternative medicine. Issues that we have to solve are concerned with the education of cancer patients, lay people and physicians on the meaning and role of alternative medicine and on the necessity for scientific evaluation of medical treatments in Japan.

Entities:  

Mesh:

Year:  2000        PMID: 10650894     DOI: 10.1007/s005209900039

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  4 in total

1.  Legal regulations of complementary and alternative medicines in different countries.

Authors:  Shailendra Saraf
Journal:  Pharmacogn Rev       Date:  2012-07

2.  Experience with and perceptions of non-prescription anthelmintics for cancer treatments among cancer patients in South Korea: A cross-sectional survey.

Authors:  Bomi Song; Kwang Joon Kim; Sung Hwan Ki
Journal:  PLoS One       Date:  2022-10-04       Impact factor: 3.752

Review 3.  Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics.

Authors:  Bomi Song; Eun Young Park; Kwang Joon Kim; Sung Hwan Ki
Journal:  Cancers (Basel)       Date:  2022-09-22       Impact factor: 6.575

4.  An Analysis of the Use of Complementary and Alternative Therapies in Patients with Breast Cancer.

Authors:  Oktay Tarhan; Ugur Muslu; Isil Somali; Cigdem Erten; Ahmet Alacacioglu; Sengul Varol; Leyla Aslan
Journal:  Breast Care (Basel)       Date:  2009-10-01       Impact factor: 2.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.